Reference number : 236-2018-2019-Q4-00049, amendment number : , agreement type : G, recipient legal name : Issekutz, Thomas B, recipient country : CA, recipient province : NS, recipient city : Halifax, recipient postal code : B3H 3J5, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 20000.0, agreement start date : 2018-12-01, agreement end date : 2019-11-30, description english : Defining critical pathways of innate immunity for precision therapy of autoimmune diseases, description french : Defining critical pathways of innate immunity for precision therapy of autoimmune diseases, expected results english : nan, expected results french : nan, additional information english : nan, additional information french : nan, owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada